Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review | SpringerLink
IJMS | Free Full-Text | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil | PLOS ONE
Long-term Efficacy and Safety of Everolimus Versus Mycopheno... : Transplantation
PDF) Conversion to everolimus in maintenance patients - Current clinical strategies
Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial - American Journal of Transplantation
Figure 1 from Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients | Semantic Scholar
De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study - American Journal of Transplantation
![PDF] Introduction of everolimus in kidney transplant recipients at a late posttransplant stage | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/52b7f3e549ab8e70c2079418becddcf9e9535b89/3-Table1-1.png "PDF] Introduction of everolimus in kidney transplant recipients at a late posttransplant stage | Semantic Scholar")
PDF] Introduction of everolimus in kidney transplant recipients at a late posttransplant stage | Semantic Scholar
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities - ScienceDirect
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities | Nefrología
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial - The Lancet
IJMS | Free Full-Text | Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities | Nefrología
An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients - ScienceDirect
Everolimus dose and trough blood levels, and laboratory values for... | Download Scientific Diagram
Effect of Early Attainment of Everolimus Target Trough Levels on Efficacy-Safety Outcomes in De Novo Kidney Transplant Recipients: 12-Month Results from US92 and TRANSFORM Studies - ATC Abstracts
De Novo Therapy with Everolimus and Low-Dose Calcineurin Inhibitors in Kidney Transplantation | Semantic Scholar
Recommendations of everolimus use in liver transplant | Gastroenterología y Hepatología (English Edition)
Frontiers | Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients | PLOS ONE
Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR) | PLOS ONE
Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients - Hartinger - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Use of everolimus in liver transplantation
